Ambev S.A. (ABEV)

In November, Seeking Alpha welcomed 24 new analysts. This article introduces them and showcases some of their top picks. Analysts highlighted include The Academic Investor, recommending Galaxy Digital; Richard Doxtator, presenting on Moonlake Immunotherapeutics; and ML Research, writing about Sezzle—all rated Strong Buys. Analysts' diverse interests range from technology (AI, in particular) to digital assets to EM equities, with investment strategies focusing on value and growth investing.

Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Ambev (ABEV) and Brown-Forman B (BF.B). But which of these two stocks offers value investors a better bang for their buck right now?

Ambev S.A. offers stable growth and resilience, supported by strong brands and geographic diversification across Latin America and Canada. Q3 results showed solid EBITDA and earnings growth despite climate and demand pressures, with robust shareholder returns via buybacks and dividends. ABEV is undervalued, with a DCF-based price target of $3.71, implying nearly 50% upside from current levels, and poised for a World Cup-driven boost in 2026.

Shares of Ambev S.A. (NYSE: ABEV - Get Free Report) have received an average recommendation of "Reduce" from the nine research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company. The average 12-month target price

Here is how Ambev (ABEV) and Chefs' Warehouse (CHEF) have performed compared to their sector so far this year.

Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Ambev (ABEV) and Diageo (DEO). But which of these two companies is the best option for those looking for undervalued stocks?

Investors love dividend stocks, especially high-yield varieties, because they offer a significant income stream and have substantial total return potential.

Ambev S.A. ( ABEV ) Q3 2025 Earnings Call October 30, 2025 11:30 AM EDT Company Participants Carlos Eduardo Lisboa - CEO & Member of Board of Executive Officers Guilherme Fleury de Figueiredo Parolari - Chief Financial, Investors Relations & Shared Services Officer and Member of Executive Board Conference Call Participants Lucas Ferreira - JPMorgan Chase & Co, Research Division Henrique Brustolin - Banco Bradesco BBI S.A., Research Division Nadine Sarwat - Sanford C.

Allianz Asset Management GmbH acquired a new position in Ambev S.A. (NYSE: ABEV) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 150,000 shares of the company's stock, valued at approximately $362,000. Other large investors also recently added

Investors interested in Beverages - Alcohol stocks are likely familiar with Ambev (ABEV) and Diageo (DEO). But which of these two stocks is more attractive to value investors?

With Q4 2025 unfolding, the stock market has generally been on a bullish run. However, there are still several cheaply priced opportunities under $10 for investors to consider, offering potentially attractive entry points from a valuation perspective.

Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Ambev (ABEV) and Diageo (DEO). But which of these two stocks presents investors with the better value opportunity right now?

Ambev S.A. remains resilient amid inflation and shifting consumer trends, supported by a strong balance sheet and attractive valuation. ABEV benefits from Brazil's robust beer culture, improving labor market, and domestic focus, shielding it from currency risks and market saturation. Despite recent volume declines, ABEV maintains solid margins, high free cash flow, low debt, and a sustainable 7%+ dividend yield.

"The true investor